Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 755s Year: 2007
Utility of FDG-PET in the diagnosis of pulmonary nodules Source: Eur Respir J 2003; 22: Suppl. 45, 245s Year: 2003
Comparison of chest x-ray, thoracic computed tomography and 18F-FDG PET/CT for staging of sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015
The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis Source: International Congress 2017 – ILDs: clinical aspects Year: 2017
Use of integrated FDG PET/CT imaging in sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 542s Year: 2006
CT and FDG PET/CT findings of pulmonary involvement in methotrexate-associated lymphoproliferative disease Source: International Congress 2018 – CC6 Interstitial lung diseases Year: 2018
Use of integrated FDG PET/CT imaging in pulmonary cacinoid tumors Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006
Relevance of FDG-PET-CT scan for the evaluation of local pleural invasion assessed by thoracoscopy in malignant pleural mesothelioma Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012
The usefulness of dynamic CT and 18 F-FDG PET to distinguish between benignancy and malignancy in solitary pulmonary nodule Source: Eur Respir J 2007; 30: Suppl. 51, 532s Year: 2007
Incidental extra pulmonary abnormalities in positive emission tomography imaging with fluro-deoxyglucose done for lung cancer staging Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008
Pleural imaging: CT scan and MRI Source: School Course 2014 - Thoracoscopy and Pleural Techniques Year: 2014
Pleural imaging: CT scan and MRI Source: ERS Course 2015 Year: 2015
The Role of PET-CT in differential diagnosis of malignant-paramalignant pleural effusion Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Diagnostic yield of computed tomography for idiophatic pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 774s Year: 2006
HRCT imaging vs chest-x-ray assessment of endothoracal sarcoidosis extent Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006
Emerging diagnostics from MRI, PET and CT studies of lung disease Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021
Assessment with STIR MR imaging and PET-CT for malignant or benign lesion in the mediastinal and hilar lymph nodes Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007
Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET) Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001
Cytology, chest computed and positron emission tomography correlations in lung cancer malignant pleural effusion. Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018